This week's Fierce Life Sci is brought to you by Clario.
In a recent survey, 89% of clinical adjudication users agreed clinical adjudication provides value to clinical trials. Why? Because using unbiased experts to evaluate a drug or device against predetermined criteria helps establish patient safety and clinical efficacy. Join two experts from Clario (formerly Bioclinica) for a discussion of these and other survey results to understand how they could impact your studies.
|
| You are currently subscribed as newsletter@newslettercollector.com |
